These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 12154198)
1. Structure of the extracellular region of HER3 reveals an interdomain tether. Cho HS; Leahy DJ Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198 [TBL] [Abstract][Full Text] [Related]
2. The extracellular domains of ErbB3 retain high ligand binding affinity at endosome pH and in the locked conformation. Kani K; Park E; Landgraf R Biochemistry; 2005 Dec; 44(48):15842-57. PubMed ID: 16313187 [TBL] [Abstract][Full Text] [Related]
3. Bivalence of EGF-like ligands drives the ErbB signaling network. Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636 [TBL] [Abstract][Full Text] [Related]
4. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47. Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL. Ohki I; Ishigaki T; Oyama T; Matsunaga S; Xie Q; Ohnishi-Kameyama M; Murata T; Tsuchiya D; Machida S; Morikawa K; Tate S Structure; 2005 Jun; 13(6):905-17. PubMed ID: 15939022 [TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3. Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor. Jorissen RN; Epa VC; Treutlein HR; Garrett TP; Ward CW; Burgess AW Protein Sci; 2000 Feb; 9(2):310-24. PubMed ID: 10716183 [TBL] [Abstract][Full Text] [Related]
10. Structures of dimeric nonstandard nucleotide triphosphate pyrophosphatase from Pyrococcus horikoshii OT3: functional significance of interprotomer conformational changes. Lokanath NK; Pampa KJ; Takio K; Kunishima N J Mol Biol; 2008 Jan; 375(4):1013-25. PubMed ID: 18062990 [TBL] [Abstract][Full Text] [Related]
11. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity. Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455 [TBL] [Abstract][Full Text] [Related]
12. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors. Sanderson MP; Dempsey PJ; Dunbar AJ Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132 [TBL] [Abstract][Full Text] [Related]
13. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation. Talavera A; Friemann R; Gómez-Puerta S; Martinez-Fleites C; Garrido G; Rabasa A; López-Requena A; Pupo A; Johansen RF; Sánchez O; Krengel U; Moreno E Cancer Res; 2009 Jul; 69(14):5851-9. PubMed ID: 19584289 [TBL] [Abstract][Full Text] [Related]
14. The insulin and EGF receptor structures: new insights into ligand-induced receptor activation. Ward CW; Lawrence MC; Streltsov VA; Adams TE; McKern NM Trends Biochem Sci; 2007 Mar; 32(3):129-37. PubMed ID: 17280834 [TBL] [Abstract][Full Text] [Related]
15. A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains. Landau M; Fleishman SJ; Ben-Tal N Structure; 2004 Dec; 12(12):2265-75. PubMed ID: 15576039 [TBL] [Abstract][Full Text] [Related]
18. Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. Graves BJ; Crowther RL; Chandran C; Rumberger JM; Li S; Huang KS; Presky DH; Familletti PC; Wolitzky BA; Burns DK Nature; 1994 Feb; 367(6463):532-8. PubMed ID: 7509040 [TBL] [Abstract][Full Text] [Related]
19. Active and inactive conformations of the epidermal growth factor receptor. Ferguson KM Biochem Soc Trans; 2004 Nov; 32(Pt 5):742-5. PubMed ID: 15494003 [TBL] [Abstract][Full Text] [Related]
20. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. Tao RH; Maruyama IN J Cell Sci; 2008 Oct; 121(Pt 19):3207-17. PubMed ID: 18782861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]